Indiana Attorney General Todd Rokita has filed a lawsuit against Eli Lilly, alleging the company contributed to inflated insulin prices over the past decade. The state is seeking injunctive relief, damages and penalties for what it describes as deceptive market…
Pharmacy
Amneal Pharmaceuticals received FDA approval for two denosumab biosimilars referencing Prolia and Xgeva. The approval, announced Dec. 22, covers Boncresa (denosumab-mobz) and Oziltus (denosumab-mobz), both used to treat conditions related to bone loss and cancer. The drugs are administered by…
The CDC will revise the U.S. childhood immunization schedule for the first time in decades, reducing routine recommendations from 18 to 11 diseases, following a December directive from President Donald Trump to compare U.S. vaccine practices with those in peer…
New Research Shows Increased Urgency to Improve Community Pharmacy Access and Reduce Gaps in Service
Sponsored
VytlOne Releases 2nd Annual Healthcare Leader Report — Reviving Access, Reclaiming Revenue: Strengthening Hospitals and Communities Through Strategic Pharmacy Expansion AMARILLO, Texas, Nov. 19, 2025 /PRNewswire/ — New research has found that nearly three-quarters of hospital and pharmacy leaders say the urgency to…
CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is interchangeable with Lantus, is available in prefilled pens for $45 per box of five pens to…
Advertisement
The FDA has fast-tracked six therapies since December 2025 through its priority review and National Priority Voucher programs, including the first approval issued under the agency’s new pilot pathway. 1. First voucher approval issued. On Dec. 9, the FDA approved…
As health systems expand specialty pharmacy services, technology transitions are becoming unavoidable — and increasingly complex. Pharmacy leaders who have already navigated these shifts say success hinges less on the software itself and more on how organizations manage people, workflows…
Drugmakers plan to raise U.S. prices on at least 350 branded medications beginning Jan. 1, including treatments for cancer, COVID-19 and RSV, according to data provided exclusively to Reuters by healthcare research firm 3 Axis Advisors. The number of increases…
Saltville-based Southwest Virginia Community Health Systems plans to open a pharmacy within its Tazewell Community Health Center in early 2026. The Tazewell Community Health Center Pharmacy will serve both patients and the general public, according to a health system news…
Corcept Therapeutics has received a complete response letter from the FDA for its new drug application for relacorilant, a treatment for hypertension caused by hypercortisolism. In the Dec. 31 letter, the FDA acknowledged that Corcept’s GRACE trial met its primary…